UnknownNot Applicable

Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated

Italy500 participantsStarted 2011-12

Plain-language summary

The purpose of this study is to describe how often advanced cancer patients experience breakthrough pain (BTcP), and to describe how this pain is treated, and how effective these treatments are.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of neoplasm in advanced stage * Chronic pain controlled for at least one week with opioids 60 mg / day morphine equivalent * 1-6 episodes of BTcP within any of 3 days previous to registration into study * Signed Informed Consent Exclusion Criteria: · More than 6 episodes of BTcP within any of 3 days previous to registration into study

What they're measuring

number of patients who experience BTcP

Timeframe: one year

treatments used to treat BTcP

Timeframe: one year

Trial details

NCT IDNCT02069067

SponsorNational Cancer Institute, Naples

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12

View on ClinicalTrials.gov More Advanced Cancer trials